• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Published: March 2014
  • Region: Global
  • 90 Pages
  • Transparency Market Research
The global smoking cessation market was valued at USD 5,086.7 million in 2012 and is expected to grow at a CAGR of 18.7% from 2013 to 2019, to reach an estimated value of USD 16,018.3million in 2019.

FEATURED COMPANIES

  • Cipla Ltd.
  • GlaxoSmithKline, Inc.
  • McNeil AB
  • NJOY, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • MORE

'Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands READ MORE >

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 List of Abbreviations
1.3.4 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Global Smoking Cessation and Nicotine De-addiction Market Overview
3.1 Market Definition and Overview
3.1.1 Nicotine Consumption, Prevalence And Trends
3.1.2 Smoking Health Hazards
3.2 R&D Pipeline
3.3 Combination Therapy for Smoking Cessation/Nicotine De-addiction
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Rising Awareness about Smoking Health Hazards and Smoking Cessation Therapy
3.4.1.2 Government intervention for smoking de-addiction
3.4.1.3 Introduction of new products will expand the market
3.4.1.4 Reimbursement for smoking cessation therapy
3.4.2 Restraints
3.4.2.1 Low awareness about smoking cessation products in the developing economies
3.4.2.2 Legal obligations dragging growth of several smoking cessation product segments
3.4.3 Opportunities
3.4.3.1 Research and Development
3.4.3.2 Market Expansion
3.5 Porter’s Five Forces Analysis for the Global Smoking Cessation and Nicotine De-addiction Products Market
3.5.1 Bargaining Power Of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from New Entrants
3.5.4 Threat from Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography

Chapter 4 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type
4.1 Introduction
4.1.1 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 - 2019 (USD Million)
4.2 Nicotine Replacement Therapy Products
4.2.1 Global Nicotine Replacement Therapy Products Market Revenue, 2011 - 2019 (USD Million)
4.2.1 Nicotine Gums
4.2.1.1 Global Nicotine Gums Market Revenue, 2011 - 2019 (USD Million)
4.2.2 Nicotine Transdermal Patches
4.2.2.1 Global Nicotine Transdermal Patches Market Revenue, 2011 - 2019 (USD Million)
4.2.3 Nicotine Lozenges
4.2.3.1 Global Nicotine Lozenges Market Revenue, 2011 - 2019 (USD Million)
4.2.4 Nicotine Sprays
4.2.4.1 Global Nicotine Sprays Market Revenue, 2011 - 2019 (USD Million)
4.3 Nicotine Inhalers
4.3.1 Global Nicotine Inhalers Market Revenue, 2011 - 2019 (USD Million)
4.4 Nicotine Sublingual Tablets
4.4.1 Global Nicotine Sublingual Tablets Market Revenue, 2011 - 2019 (USD Million)
4.5 Electronic Cigarettes (E-cigarettes)
4.5.1 Global E-cigarettes Market Revenue, 2011 - 2019 (USD Million)
4.6 Drug Therapy
4.6.1 Global Drug Therapy Market for Smoking Cessation, 2011 - 2019 (USD Million)
4.6.2 Zyban (Bupropion)
4.6.3 Global Zyban Market Revenue, by Geography, 2011 – 2019 (USD Million)
4.6.3.1 Global Zyban Market Revenue, 2011 - 2019 (USD Million)
4.6.4 Chantix/Champix (varenicline)
4.6.5 Global Champix/Chantix Market Revenue, by Geography, 2011 – 2019 (USD Million)
4.6.5.1 Global Chantix/Champix Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
5.1 Introduction
5.1.1 Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2011 – 2019 (USD Million)
5.2 North America
5.2.1 North America Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.2.2 North America Smoking Cessation and Nicotine De-addiction Products Market, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.3.2 European Smoking Cessation and Nicotine De-addiction Products, Market revenue, by Geography, 2011 – 2019 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.4.2 Asia-Pacific Smoking Cessation and Nicotine De-addiction Products Market, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.5.2 Rest of the World Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Heat Map Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market
6.1.1 Methodology
6.1.2 Heat Map Analysis for the Global Smoking Cessation and Nicotine De-addiction Products Market, by key players, 2012

Chapter 7 Recommendations
7.1 Investment In Private Label Brands
7.2 Asia-Pacific Offering Various Opportunities to Smoking Cessation Market
7.3 Diversification to Electronic Cigarettes Business
7.4 Expansion Through Mergers and Acquisitions

Chapter 8 Company Profiles
8.1 Cipla Ltd.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Development
8.2 GlaxoSmithKline, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Imperial Tobacco Company of India (ITC Ltd).
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Development
8.4 McNeil AB
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 NJOY, Inc.
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Business Strategies
8.5.4 Recent Development
8.6 Novartis International AG
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Development
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategy
8.7.5 Recent Development
8.8 Revolymer PLC
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Development
8.9 Takeda Pharmaceutical Co. Ltd.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Development
8.10 VMR Products LLC
8.10.1 Company Profile
8.10.2 Product Portfolio
8.10.3 Business Strategies

List of Figures

FIG. 1 Global Smoking Cessation and Nicotine De-addiction Products Market – Market Segmentation
FIG. 1 Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, 2010-2019 (USD Million)
FIG. 2 Porter’s Five Forces Analysis for Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2012
FIG. 3 Market Attractiveness Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2012
FIG. 4 Global Nicotine Replacement Therapy Products Market Revenue, 2011 - 2019 (USD Million)
FIG. 5 Global Nicotine Gums Market Revenue, 2011 – 2019 (USD Million)
FIG. 6 Global Nicotine Transdermal Patched Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Nicotine Lozenges Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Nicotine Sprays Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Nicotine Inhalers Market Revenue, 2011 - 2019 (USD Million)
FIG. 10 Global Nicotine Sublingual Tablets Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global E-cigarettes Market Revenue, 2011-2019 (USD Million)
FIG. 12 Global Zyban Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Chantix/ Champix Market Revenue, 2011- 2019 (USD Million)
FIG. 14 Comparative Analysis : Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2012 and 2019 (USD million)
FIG. 15 North America Smoking Cessation and Nicotine De-addiction Products, Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 European Smoking Cessation and Nicotine De-addiction Products, Market Revenue, by Geography, 2011 – 2019 (USD Million)
FIG. 17 Asia-Pacific Smoking Cessation and Nicotine De-addiction Products, Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Rest of the World Smoking Cessation and Nicotine De-addiction Products, Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Heat Map Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Key Players (2012)
FIG. 20 Cipla Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 GlaxoSmithKline Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 ITC Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Johnson & Johnson Consumer Segment**, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Novartis International AG, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Pfizer Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 Revolymer PLC., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Takeda Pharmaceutical Co. Ltd., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Smoking Cessation and Nicotine De-addiction Products Market
TABLE 2 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Types, 2011 - 2019 (USD Million)
TABLE 3 Global Zyban Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 4 Global Champix/Chantix Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 5 Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2011 – 2019 (USD Million)
TABLE 6 North America Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
TABLE 7 Europe Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
TABLE 8 Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
TABLE 9 Rest of the World Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)

Smoking cessation products are a better alternative for tobacco and cigarette addicts. Smoking cessation products market comprises nicotine replacement therapy (NRT) products, prescription drugs and electronic cigarettes. With the rising incidences of lung cancer, and other diseases such as respiratory and cardiac disorders due to smoking, governments of various countries have started taking initiatives for controlling cigarette addiction. The U.S. Centers for Disease Control and Prevention (CDC) stated that 2011 witnessed around 44 million adults addicted to cigarette smoking in the U.S.,with majority being from the low-income class. Higher taxes on tobacco products, ban on smoking in public places, benefits and assistance for smoking cessation therapies were some of the important policies implemented in order to motivate addicts to quit smoking.

Nicotine replacement therapy (NRT) products comprise nicotine gums, patches, lozenges, sprays, inhalers and sublingual tablets. All these products are available over-the-counter, except for Nicotrol nicotine inhalers and nasal sprays which are sold only with prescription. The regulations on sales of NRT products differ from country to country. Nicotine gums are the oldest products in the market and cover around 38% share of the total NRT market. The market for nicotine lozenges is expected to grow at a faster rate owing to convenient use, low cost and easy availability. Nicotine transdermal patches are the second most widely used NRT products for smoking cessation. Major players in the NRT market include GlaxoSmithKline, Novartis and Johnson & Johnson. First line drug therapy for smoking cessation includes Zyban by GlaxoSmithKline, and Chantix (Champix in countries other than the U.S.) by Pfizer. The drug therapy market has suffered from consistent criticism, as suicidal attempts were reported by patients prescribed with either of these drugs. For the same reason, sales of these drugs has been witnessing decline for the past few years.

Electronic cigarettes is the largest and the fastest growing segment in the smoking cessation market. More than 80% of the e-cigarette market share lies with Europe and North America. Regulation of e-cigarettes as medical devices or tobacco products are still in debate. Lobbyists across the globe are trying to influence regulatory agencies to ease restrictions on e-cigarettes. Although this has not yet affected market growth, restrictions and bans on the use of e-cigarettes may adversely affect market growth in the near future. The electronic cigarettes market was valued at USD 1,662.5 million in 2012 and is expected to grow at a CAGR of 33% from 2013 to 2019, to reach an estimated value of USD 12,238.4million in 2019. Key players in the e-cigarettes market include VMR Products LLC, NJOY, Lorillard, Inc., Nicoventures and Altria Group.

Geographically, North America leads the smoking cessation market followed by the European countries. Asia Pacific and Rest of the World have been identified as the most profitable markets in the near future. Increasing awareness about alternatives to cigarette smoking have increased the demand for smoking cessation products in these regions. Absence of strong market players, unaddressed market needs, comparatively lenient regulations and rising per capita income has made the Asia Pacific market more attractive.

- Cipla Ltd.
- GlaxoSmithKline, Inc.
- Imperial Tobacco Company of India (ITC Ltd).
- McNeil AB
- NJOY, Inc.
- Novartis International AG
- Pfizer, Inc.
- Revolymer PLC
- Takeda Pharmaceutical Co. Ltd.
- VMR Products LLC

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos